Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer

Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma

(2014) M Gkotzamanidou et al.   BRITISH JOURNAL OF CANCER

Nucleotide excision repair: Why is it not used to predict response to platinum-based chemotherapy?

(2014) Nikola A. Bowden   CANCER LETTERS

Sensitivity and specificity of the empirical lymphocyte genome sensitivity (LGS) assay: implications for improving cancer diagnostics

(2014) Diana Anderson et al.   FASEB JOURNAL

Ovarian cancer

(2014) Gordon C Jayson et al.   LANCET

Chromatin structure in double strand break repair

(2013) Anastas Gospodinov et al.   DNA REPAIR

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients

(2013) Joyce F. Liu et al.   GYNECOLOGIC ONCOLOGY

Kinetics of nuclear phosphorylation ( -H2AX) in human lymphocytes treated in vitro with UVB, bleomycin and mitomycin C

(2013) R. Scarpato et al.   MUTAGENESIS

Evaluating cell lines as tumour models by comparison of genomic profiles

(2013) Silvia Domcke et al.   Nature Communications

Histotype-specific copy-number alterations in ovarian cancer

(2012) Ruby YunJu Huang et al.   BMC Medical Genomics

Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs

(2012) Dimitra T. Stefanou et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

DNA repair gene variants in relation to overall cancer risk: a population-based study

(2012) Anthony J. Alberg et al.   CARCINOGENESIS

Therapeutic strategies in epithelial ovarian cancer

(2012) Ayako Kim et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MutS homologue hMSH5: role in cisplatin-induced DNA damage response

(2012) Joshua D Tompkins et al.   Molecular Cancer

Inter-laboratory variation in DNA damage using a standard comet assay protocol

(2012) Lykke Forchhammer et al.   MUTAGENESIS

A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma

(2011) M. Rotunno et al.   Cancer Prevention Research

Blood-Based Gene Expression Signatures in Non-Small Cell Lung Cancer

(2011) T. Zander et al.   CLINICAL CANCER RESEARCH

DNA damage response and transcription

(2011) Saskia Lagerwerf et al.   DNA REPAIR

DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

(2011) Li-E Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA Methylation Array Analysis Identifies Profiles of Blood-Derived DNA Methylation Associated With Bladder Cancer

(2011) Carmen J. Marsit et al.   JOURNAL OF CLINICAL ONCOLOGY

The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway

(2010) Michael R. Lieber   Annual Review of Biochemistry

A minority of foci or pan-nuclear apoptotic staining of  H2AX in the S phase after UV damage contain DNA double-strand breaks

(2010) S. de Feraudy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells

(2009) Florian T Unger et al.   BMC CANCER

Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: Mechanistic insights

(2009) Larry H. Thompson et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links

(2009) A. Z. Al-Minawi et al.   NUCLEIC ACIDS RESEARCH

An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer

(2009) Andrew E. Teschendorff et al.   PLoS One

Ovarian Cancer Pathogenesis: A Model in Evolution

(2009) Alison M. Karst et al.   Journal of Oncology

Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy

(2008) P.H. Clingen et al.   BIOCHEMICAL PHARMACOLOGY

The endless tale of non-homologous end-joining

(2008) Eric Weterings et al.   CELL RESEARCH

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer

(2008) Johanne Weberpals et al.   INTERNATIONAL JOURNAL OF CANCER

Death Receptor-Induced Activation of the Chk2- and Histone H2AX-Associated DNA Damage Response Pathways

(2008) S. Solier et al.   MOLECULAR AND CELLULAR BIOLOGY

Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study

(2008) Martin Widschwendter et al.   PLoS One